Tegafur/gimeracil/oteracil (TS-1)-induced erythroderma with an extensive mucosal involvement and hand-foot syndrome

Eur J Dermatol. 2017 Jun 1;27(3):323-325. doi: 10.1684/ejd.2017.2999.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antimetabolites, Antineoplastic
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Colonic Neoplasms / drug therapy
  • Dermatitis, Exfoliative / chemically induced*
  • Drug Combinations
  • Drug Eruptions / etiology*
  • Drug Eruptions / pathology
  • Fluorouracil / adverse effects
  • Hand-Foot Syndrome / etiology*
  • Humans
  • Leucovorin / adverse effects
  • Liver Neoplasms / drug therapy
  • Liver Neoplasms / secondary
  • Male
  • Organoplatinum Compounds / adverse effects
  • Oxonic Acid / adverse effects
  • Pyridines / adverse effects
  • Tegafur / adverse effects

Substances

  • Antimetabolites, Antineoplastic
  • Drug Combinations
  • Organoplatinum Compounds
  • Pyridines
  • oxiplatin
  • Tegafur
  • Oxonic Acid
  • Leucovorin
  • Fluorouracil
  • gimeracil

Supplementary concepts

  • Folfox protocol